Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Jun;82(2):349–357. doi: 10.1111/j.1476-5381.1984.tb10769.x

An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents.

K A Kane, J R Parratt, F M Williams
PMCID: PMC1987024  PMID: 6733362

Abstract

Reperfusion-induced arrhythmias were elicited in the pentobarbitone-anaesthetized rat by occlusion of the left main coronary artery and subsequent release. These arrhythmias were rapid in onset, occurring within 20 s after release of the ligature, and were of short duration (1-2 min). Their severity was dependent upon the duration of the preceding occlusion. A 5 or 15 min occlusion period produced the most severe arrhythmias on release, the incidence of ventricular fibrillation being 56 and 50% respectively. Evidence that reperfusion had occurred was provided by fluorescein dye distribution and intramyocardial temperature studies. The severity of reperfusion arrhythmias and mortality was unaffected by bilateral vagotomy, beta-adrenoceptor blockade by atenolol (2 mg kg-1 i.v.) or a combination of the two. The incidence of reperfusion-induced ventricular fibrillation was significantly reduced by Org 6001 (which blocks the fast inward sodium current), melperone (which acutely prolongs the cardiac action potential duration) and bepridil (which blocks both fast and slow inward currents). It was unaffected by nitroglycerine and the calcium antagonists verapamil, prenylamine and nifedipine. We have shown that reperfusion-induced cardiac arrhythmias can be consistently elicited in the anaesthetized rat and that they are particularly susceptible to drugs that can block the fast inward sodium current.

Full text

PDF
349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arlock P., Gullberg B., Olsson S. R. Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine. Naunyn Schmiedebergs Arch Pharmacol. 1978 Aug;304(1):27–36. doi: 10.1007/BF00501374. [DOI] [PubMed] [Google Scholar]
  2. Axelrod P. J., Verrier R. L., Lown B. Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and release. Am J Cardiol. 1975 Nov;36(6):776–782. doi: 10.1016/0002-9149(75)90459-2. [DOI] [PubMed] [Google Scholar]
  3. Balke C. W., Kaplinsky E., Michelson E. L., Naito M., Dreifus L. S. Reperfusion ventricular tachyarrhythmias: correlation with antecedent coronary artery occlusion tachyarrhythmias and duration of myocardial ischemia. Am Heart J. 1981 Apr;101(4):449–456. doi: 10.1016/0002-8703(81)90135-6. [DOI] [PubMed] [Google Scholar]
  4. Bergey J. L., Nocella K., McCallum J. D. Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine. Eur J Pharmacol. 1982 Jul 9;81(2):205–216. doi: 10.1016/0014-2999(82)90438-1. [DOI] [PubMed] [Google Scholar]
  5. Brooks W. W., Verrier R. L., Lown B. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion. Cardiovasc Res. 1980 May;14(5):295–302. doi: 10.1093/cvr/14.5.295. [DOI] [PubMed] [Google Scholar]
  6. Clark C., Foreman M. I., Kane K. A., McDonald F. M., Parratt J. R. Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods. 1980 Jun;3(4):357–368. doi: 10.1016/0160-5402(80)90077-7. [DOI] [PubMed] [Google Scholar]
  7. Coker S. J., Parratt J. R. Nifedipine reduces arrhythmias but does not alter prostanoid release during coronary artery occlusion and reperfusion in anaesthetised greyhounds. J Cardiovasc Pharmacol. 1983 May-Jun;5(3):406–417. doi: 10.1097/00005344-198305000-00010. [DOI] [PubMed] [Google Scholar]
  8. Fagbemi O., Parratt J. R. Calcium antagonists prevent early post-infarction ventricular fibrillation. Eur J Pharmacol. 1981 Nov 5;75(4):179–185. doi: 10.1016/0014-2999(81)90543-4. [DOI] [PubMed] [Google Scholar]
  9. Gillis R. A. Role of the nervous system in the arrhythmias produced by coronary occlusion in the cat. Am Heart J. 1971 May;81(5):677–684. doi: 10.1016/0002-8703(71)90011-1. [DOI] [PubMed] [Google Scholar]
  10. Kane K. A., Winslow E. Antidysrhythmic and electrophysiological effects of a new antianginal agent, bepridil. J Cardiovasc Pharmacol. 1980;2(2):193–203. doi: 10.1097/00005344-198003000-00010. [DOI] [PubMed] [Google Scholar]
  11. Lubbe W. F., Daries P. S., Opie L. H. Ventricular arrhythmias associated with coronary artery occlusion and reperfusion in the isolated perfused rat heart: a model for assessment of antifibrillatory action of antiarrhythmic agents. Cardiovasc Res. 1978 Apr;12(4):212–220. doi: 10.1093/cvr/12.4.212. [DOI] [PubMed] [Google Scholar]
  12. Lubbe W. F., McFadyen M. L., Muller C. A., Worthington M., Opie L. H. Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. Am J Cardiol. 1979 Mar;43(3):533–540. doi: 10.1016/0002-9149(79)90010-9. [DOI] [PubMed] [Google Scholar]
  13. Millar J. S., Vaughan Williams E. M. Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs. Br J Pharmacol. 1983 Jul;79(3):701–709. doi: 10.1111/j.1476-5381.1983.tb10007.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Naito M., Michelson E. L., Kmetzo J. J., Kaplinsky E., Dreifus L. S. Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation. Circulation. 1981 Jan;63(1):70–79. doi: 10.1161/01.cir.63.1.70. [DOI] [PubMed] [Google Scholar]
  15. Penkoske P. A., Sobel B. E., Corr P. B. Disparate electrophysiological alterations accompanying dysrhythmia due to coronary occlusion and reperfusion in the cat. Circulation. 1978 Dec;58(6):1023–1035. doi: 10.1161/01.cir.58.6.1023. [DOI] [PubMed] [Google Scholar]
  16. Petersen E. N. Pre- and postsynaptic alpha-adrenoceptor antagonism by neuroleptics in vivo. Eur J Pharmacol. 1981 Feb 19;69(4):399–405. doi: 10.1016/0014-2999(81)90443-x. [DOI] [PubMed] [Google Scholar]
  17. Ribeiro L. G., Brandon T. A., Debauche T. L., Maroko P. R., Miller R. R. Antiarrhythmic and hemodynamic effects of calcium channel blocking agents during coronary arterial reperfusion. Comparative effects of verapamil and nifedipine. Am J Cardiol. 1981 Jul;48(1):69–74. doi: 10.1016/0002-9149(81)90573-7. [DOI] [PubMed] [Google Scholar]
  18. SELYE H., BAJUSZ E., GRASSO S., MENDELL P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology. 1960 Oct;11:398–407. doi: 10.1177/000331976001100505. [DOI] [PubMed] [Google Scholar]
  19. SEWELL W. H., KOTH D. R., HUGGINS C. E. Ventricular fibrillation in dogs after sudden return of flow to the coronary artery. Surgery. 1955 Dec;38(6):1050–1053. [PubMed] [Google Scholar]
  20. Salako L. A., Williams V., Wittig J. H. Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism. Br J Pharmacol. 1976 Jun;57(2):251–262. doi: 10.1111/j.1476-5381.1976.tb07475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schaffer W. A., Cobb L. A. Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. N Engl J Med. 1975 Aug 7;293(6):259–262. doi: 10.1056/NEJM197508072930601. [DOI] [PubMed] [Google Scholar]
  22. Schoeneberger A. S., Verrier R. L., Lown B. Protective effect of prenylamine against vulnerability to ventricular fibrillation in the normal and ischemic canine myocardium. Proc Soc Exp Biol Med. 1979 May;161(1):56–59. doi: 10.3181/00379727-161-40489. [DOI] [PubMed] [Google Scholar]
  23. Sheridan D. J., Penkoske P. A., Sobel B. E., Corr P. B. Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest. 1980 Jan;65(1):161–171. doi: 10.1172/JCI109647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stockman M. B., Verrier R. L., Lown B. Effect of nitroglycerin on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am J Cardiol. 1979 Feb;43(2):233–238. doi: 10.1016/s0002-9149(79)80009-0. [DOI] [PubMed] [Google Scholar]
  25. Vogel S., Crampton R., Sperelakis N. Blockade of myocardial slow channels by bepridil (CERM-1978). J Pharmacol Exp Ther. 1979 Sep;210(3):378–385. [PubMed] [Google Scholar]
  26. Winslow E., Kelly M. E., Law E. A. Effect of org 6001 on reperfusion dysrhythmias and lactate dehydrogenase release in isolated rat hearts: comparison with propranolol and lignocaine. J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):425–434. doi: 10.1097/00005344-198007000-00009. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES